Director of MPS
John J. Burke
Thursday, October 11 | 2:00 PM EDT
FairWarning Executive Series Webinar
Drug diversion has surged in healthcare in recent years, creating hefty impacts for both patients and care providers. This is fueled largely by the opioid epidemic which claimed over 49,000 deaths last year – a 410% increase from 2002.
Patient safety is the number one concern for care providers surrounding drug diversion. Further Impacts to care providers come in the form of health and safety concerns, regulatory liability, mandated participation in federally sponsored programs, financial loss, unwanted media attention, and a breakdown of trust between patient and provider.
The Department of Justice and the U.S. Drug Enforcement Administration are pouring vast resources into tackling the growing problem of drug diversion. Efforts include diversion investigators, intelligence research specialists and special agents who have spearheaded over 54 enforcement actions and 283 administrative actions so far this year.
This leaves care providers with the complex task of creating a comprehensive drug diversion monitoring program. But the burning question for many care providers is “Where do I start?” and “What do I do If I catch drug diversion in my facility?”
There are steps care providers can take to detect, investigate, mitigate and remediate incidents of drug diversion. By doing so, they can help ensure trust between patient and provider.
In this webinar you will learn:
Commander John Burke
Pharmaceutical Diversion Education Inc
Trent J. Long
Director of Managed Privacy Services